13 • Til patienter med dekompenseret leversygdom og levertransplanterede patienter anbefales ikke indstilling af behandling.
14 YMDD variant HBV, a switch to or addition of an alternative agent should be considered (see section 5.1). • In patients with decompensated liver disease and liver transplant recipients, treatment cessation is not recommended.